125742 S1 M5 5314 vr mvr 10083 att04

Pfizer Documents (PHMPT/FDA)

Pfizer Bla Submission

Pfizer 16 Plus Documents

2

Download PDF ↗ Live URL (may be dead)

Document text

VACCINE RESEARCH  PEARL RIVER   
TITLE:  Training Event Form  Doc. Number:  
VR-SOP-QU-10321 -FM01  Vers ion: 8.0 
Doc. Alias: SPI -1061A   
 
PFIZER CONFIDENT IAL 
Page 1 
 1. TRAINING EVENT  
Table  1. Training Event -Form  
Course Number  VR-MVP -10074  Version # NA 
1.0 Eff. Date   NA 
(DD-MMM -YYYY)  
16-NOV -2020  
 
Course Title  
(Can be abbreviated)  Validation Protocol for the SARS -CoV -2 mNeo nGreen Virus Microneutralization 
Assay  
 
 
Training Method            Interactiv e (Instructor -led)  Read -Only  
 Computer -based/e -Learning  Training Credit (Attach Documentation)  
Assessment  Method      Skill Assessment/ On the Job Training   NA 
Type of  Training           Initial  Revision  Refresher  Re-Training Re-Certificat ion 
 Print Name  Signature  Training Date  
(DD-MMM -YYYY)  P2L 
 NT ID 
(milga tt) P/F/NA  
1   16-Nov-2020  P 
2   16-Nov-2020  P 
3   16-Nov-2020  P 
4   16-Nov-2020  P 
5   16-Nov-2020  P 
6   16-Nov-2020  P 
7   16-Nov-2020  P 
8   16-Nov-2020  P 
9      
10      
11      
12      
Trainer   NA                                                              Signature/Date                                                        NA 
 Print Name  
Co-Facilitator  NA                                                                    Signature/Date                                                        NA 
Print Name  
Training Admin  Print Name  Signature  Date  
    
DocuSign Envelope ID: EAC7930A-C6C4-448E-8348-D0EEF25D30D5
Caitlin Allison DeGrose
George Phelan
Kent Ozcan
Kyle Jacobs
Tyler Garretson
November 23, 2020
090177e1962afb2b\Approved\Approved On: 09-Feb-2021 14:02 (GMT)
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
x
x
x
(b) (6)
(b) (6)
(b) (6)
(b) (6)
(b) (6)
(b) (6)
(b) (6), (b) (4)
(b) (6), (b) (4)
(b) (6), (b) (4
(b) (6)
(b) (6), (b) (4)
(b) (6)
(b)(4)
(b)(4)
(b)(4)
(b)(4)
FDA-CBER-2021-5683-0779529
090177e1962afb2b\Approved\Approved On: 09-Feb-2021 14:02 (GMT)
N/A
N/A
N/A
N/A
N/A
X
X
(b) (6)
 
(b) (6)
(b) (6)
(b) (6)
(b) (6)
(b) (6)
(b) (6)
(b) (6)
(b) (6), (b) (4)
(b) (6), (b) (4)
(b) (6)
(b) (6)
(b) (6)
(b) (6)
(b) (6)
(b) (6)
(b) (6)
(b) (6), (b) (4)
(b) (6)
(b) (6)
(b) (6)
(b) (6)
FDA-CBER-2021-5683-0779530